EIF3H expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.854600E-01
Normal-vs-Stage2
9.523000E-01
Normal-vs-Stage3
6.063000E-01
Normal-vs-Stage4
2.162400E-01
Stage1-vs-Stage2
5.441800E-01
Stage1-vs-Stage3
8.404800E-01
Stage1-vs-Stage4
6.137800E-02
Stage2-vs-Stage3
4.618800E-01
Stage2-vs-Stage4
1.025820E-01
Stage3-vs-Stage4
1.395040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.777200E-01
Normal-vs-AfricanAmerican
2.225800E-01
Normal-vs-Asian
7.117400E-01
Caucasian-vs-AfricanAmerican
1.693410E-01
Caucasian-vs-Asian
5.132400E-01
AfricanAmerican-vs-Asian
4.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.722200E-01
Normal-vs-Female
8.366600E-01
Male-vs-Female
3.713000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.987160E-01
Normal-vs-Age(41-60Yrs)
8.845000E-01
Normal-vs-Age(61-80Yrs)
7.856600E-01
Normal-vs-Age(81-100Yrs)
5.536200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.279390E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.613800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.685990E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.410550E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.178600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.424390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.210600E-01
Normal-vs-Daily Drinker
9.195400E-01
Normal-vs-Weekly Drinker
3.832400E-01
Normal-vs-Occasional Drinker
3.684800E-01
Normal-vs-Social Drinker
7.493600E-01
Non Drinker-vs-Daily Drinker
8.345200E-01
Non Drinker-vs-Weekly Drinker
4.115200E-01
Non Drinker-vs-Occasional Drinker
2.300400E-02
Non Drinker-vs-Social Drinker
9.029400E-01
Daily Drinker-vs-Weekly Drinker
3.236400E-01
Daily Drinker-vs-Occasional Drinker
7.286400E-02
Daily Drinker-vs-Social Drinker
7.773400E-01
Weekly Drinker-vs-Occasional Drinker
5.978400E-03
Weekly Drinker-vs-Social Drinker
4.814800E-01
Occasional Drinker-vs-Social Drinker
3.425800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.398600E-01
Normal-vs-Grade 2
1.245580E-01
Normal-vs-Grade 3
1.366040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.550300E-02
Grade 1-vs-Grade 3
6.622600E-03
Grade 1-vs-Grade 4
4.398600E-01
Grade 2-vs-Grade 3
1.048240E-01
Grade 2-vs-Grade 4
1.245580E-01
Grade 3-vs-Grade 4
1.366040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.901600E-01
Normal-vs-NonDiabetic
8.724600E-01
Diabetic-vs-NonDiabetic
3.441200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.429600E-01
Normal-vs-NoPancreatitis
9.767200E-01
Pancreatitis-vs-NoPancreatitis
8.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.133200E-01
Normal-vs-N1
9.096400E-01
N0-vs-N1
4.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.129400E-01
Normal-vs-TP53-NonMutant
6.484400E-01
TP53-Mutant-vs-TP53-NonMutant
2.16329999999099E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
